Silymarin's Advantage on Graft Effectiveness

Clinical trial NCT06801886 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06801886
Sponsor: University Hospital, Martin
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Posttransplant Diabetes Mellitus Acute Graft Rejection Biopsy Proven Acute Rejection Antibody Mediated Rejection of Kidney Transplant Arterial Hypertension, Chronic Kidney Disease

Start date: 2020-01-07
Primary completion: 2025-12-31
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.